Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Soslow

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
Journal of Pathology and Translational Medicine|August 29, 2020
Evaluation of human papillomavirus (HPV) prediction using the International Endocervical Adenocarcinoma Criteria and Classification system, compared to p16 immunohistochemistry and HPV RNA in-situ hybridizationHezhen Ren, Jennifer Pors, Christine Chow, et al.
Gynecologic Oncology|January 25, 2006
The significance of cytological mesothelial atypia diagnosed from peritoneal washings performed during risk-reducing salpingo-oophorectomyRam Eitan, Robert Soslow, Oscar Lin, et al.
The American Journal of Surgical Pathology|May 19, 2025
HPV42: A Common Low-Risk HPV Type Associated With Distinctive Cervicovaginal and Cutaneous NeoplasiaKaren L Talia, David Hawkes, Gloria Zhang, et al.
The American Journal of Surgical Pathology|October 13, 2011
Diagnosis of serous tubal intraepithelial carcinoma based on morphologic and immunohistochemical features: a reproducibility studyKala Visvanathan, Russell Vang, Patricia Shaw, et al.
The American Journal of Surgical Pathology|October 15, 2005
Expression of WT1, CA 125, and GCDFP-15 as useful markers in the differential diagnosis of primary ovarian carcinomas versus metastatic breast cancer to the ovaryCarmen Tornos, Robert Soslow, Shirley Chen, et al.
Gynecologic Oncology|August 2, 2003
Role of KRAS and BRAF gene mutations in mucinous ovarian carcinomaMary L Gemignani, Alan C Schlaerth, Faina Bogomolniy, et al.
Radiology|January 8, 2011
The value of MR imaging when the site of uterine cancer origin is uncertainHebert Alberto Vargas, Oguz Akin, Junting Zheng, et al.
The Journal of Pathology|October 13, 2011
TP53 mutations in serous tubal intraepithelial carcinoma and concurrent pelvic high-grade serous carcinoma--evidence supporting the clonal relationship of the two lesionsElisabetta Kuhn, Robert J Kurman, Russell Vang, et al.
Gynecologic Oncology|March 16, 2006
Retroperitoneal nodal metastasis in primary and recurrent granulosa cell tumors of the ovaryNadeem R Abu-Rustum, Antonella Restivo, Joseph Ivy, et al.
International Journal of Surgical Pathology|December 12, 2024
Late Recurrence of a Growing Teratoma Syndrome-Like Lesion in a 54-Year-Old Female Patient: A Follow-up Case ReportGabriela Patrichi, Marius Beleaua, Andrei Patrichi, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Journal of Pathology and Translational Medicine|August 29, 2020
Evaluation of human papillomavirus (HPV) prediction using the International Endocervical Adenocarcinoma Criteria and Classification system, compared to p16 immunohistochemistry and HPV RNA in-situ hybridizationHezhen Ren, Jennifer Pors, Christine Chow, et al.
Gynecologic Oncology|January 25, 2006
The significance of cytological mesothelial atypia diagnosed from peritoneal washings performed during risk-reducing salpingo-oophorectomyRam Eitan, Robert Soslow, Oscar Lin, et al.
The American Journal of Surgical Pathology|May 19, 2025
HPV42: A Common Low-Risk HPV Type Associated With Distinctive Cervicovaginal and Cutaneous NeoplasiaKaren L Talia, David Hawkes, Gloria Zhang, et al.
The American Journal of Surgical Pathology|October 13, 2011
Diagnosis of serous tubal intraepithelial carcinoma based on morphologic and immunohistochemical features: a reproducibility studyKala Visvanathan, Russell Vang, Patricia Shaw, et al.
The American Journal of Surgical Pathology|October 15, 2005
Expression of WT1, CA 125, and GCDFP-15 as useful markers in the differential diagnosis of primary ovarian carcinomas versus metastatic breast cancer to the ovaryCarmen Tornos, Robert Soslow, Shirley Chen, et al.
Gynecologic Oncology|August 2, 2003
Role of KRAS and BRAF gene mutations in mucinous ovarian carcinomaMary L Gemignani, Alan C Schlaerth, Faina Bogomolniy, et al.
Radiology|January 8, 2011
The value of MR imaging when the site of uterine cancer origin is uncertainHebert Alberto Vargas, Oguz Akin, Junting Zheng, et al.
The Journal of Pathology|October 13, 2011
TP53 mutations in serous tubal intraepithelial carcinoma and concurrent pelvic high-grade serous carcinoma--evidence supporting the clonal relationship of the two lesionsElisabetta Kuhn, Robert J Kurman, Russell Vang, et al.
Gynecologic Oncology|March 16, 2006
Retroperitoneal nodal metastasis in primary and recurrent granulosa cell tumors of the ovaryNadeem R Abu-Rustum, Antonella Restivo, Joseph Ivy, et al.
International Journal of Surgical Pathology|December 12, 2024
Late Recurrence of a Growing Teratoma Syndrome-Like Lesion in a 54-Year-Old Female Patient: A Follow-up Case ReportGabriela Patrichi, Marius Beleaua, Andrei Patrichi, et al.
Pageof 5